MacroGenics, Inc. (MGNX)
4.205
+0.16
(+3.83%)
USD |
NASDAQ |
Jun 03, 16:00
4.205
0.00 (0.00%)
After-Hours: 19:59
MacroGenics Market Cap : 267.28M for June 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 383.59B |
| Catalyst Pharmaceuticals, Inc. | 3.828B |
| Gilead Sciences, Inc. | 160.17B |
| Incyte Corp. | 19.56B |
| Akari Therapeutics Plc | 16.99M |
Market Cap Related Metrics
| PS Ratio | 1.694 |
| PEG Ratio | -0.1510 |
| Price to Book Value | 12.61 |
| Price | 4.205 |
| Earnings Yield | -26.44% |
| PEGY Ratio | -0.1510 |